The mayor reported on the consultations for the production of vaccines from COVID-19

The mayor of Moscow Sergei Sobyanin announced on Thursday that consultations were underway to start post-clinical trials of vaccines against coronavirus Institute name Gamalei in the capital.

"Institute name Gamalei very well conducted clinical trials and received an almost finished vaccine. We are consulting to begin post-clinical trials in Moscow. That is, in the near future the Ministry of health will register the vaccine and start production. First experienced, then industrial mass", - said Sobyanin in an interview published on the website of "Komsomolskaya Pravda".

The mayor expressed hope that in September-November it will be possible to get more vaccines for the vaccination. This will help to solve the problem of reducing immunity among people.

Recent data on the situation of COVID-19 in Russia and the world presented on the portal stopmanager.of the Russian Federation.